In a Greek study (Murray et al, 2006), somatic mutations of EGFR were reported in 15% of a group of 60 patients with NSCLC, while Dova et al (2007) reported two mutations in 50 Greek patients with cancer of unknown primary. Here, EGFR is linked to cancer.